Daniel Imhoff

Daniel Imhoff is an accomplished analytical scientist with extensive experience in method development, particularly HPLC. Currently serving as Lead Analytical Scientist at Nexus Pharmaceuticals, Inc. since July 2019, Daniel has progressed through various roles including Analytical Scientist III. Prior experience includes positions at Adello Biologics, LLC as QC Analyst IV, and Celgene as Sr. Scientist, where Daniel authored and executed study protocols and reports. Earlier roles at Morton Grove Pharmaceutical, Dentsply Pharmaceutical, and Abbott showcased proficiency in HPLC assays, troubleshooting, and laboratory management. Daniel holds a Master of Science in Analytical Chemistry and a Certificate in Regulatory Science from the Illinois Institute of Technology, alongside bachelor's degrees in Forensic Chemistry and Biological Sciences from Ohio University.